Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana (NYSE:HUM) reported 1Q26 GAAP EPS of $9.83 and Adjusted EPS of $10.31, and affirmed FY2026 Adjusted EPS guidance of at least $9.00 while revising FY2026 GAAP EPS guidance to at least $8.36. Insurance benefit ratio for 1Q26 was 89.4%; FY2026 guidance for the insurance benefit ratio is 92.75% ±25 bps. The company cited Medicare Advantage membership growth (~25% YoY), CenterWell patient growth (+110,500 sequential), recent MaxHealth acquisition integration, and new state-based contracts as drivers of expansion.
CenterWell Pharmacy (NYSE:HUM) and Mark Cuban Cost Plus Drug Company are expanding a partnership to develop employer-focused prescription solutions. Cost Plus Drugs selected CenterWell as a pharmacy partner and CenterWell will adopt the SwiftyRx™ platform to support medication order intake and home delivery for eligible Humana associates.
The collaboration aims to streamline onboarding, automate benefit checks, reduce cost-to-fill, and improve operational efficiency to lower patient medication costs.
CenterWell (NYSE: HUM) introduced the CenterWell Fulfillment Index on April 20, 2026, a new national measure built from 72 indicators to track wellbeing in adults 62+. The Index found 54% of adults 62+ report feeling fulfilled and highlights dips around ages 65–69, aiming to guide whole-person care.
The Index is intended for routine use by care teams to identify nonmedical needs tied to purpose, connection, comfort, independence, and security.
Humana (NYSE: HUM) declared a quarterly cash dividend of $0.885 per share, payable on July 31, 2026 to stockholders of record at the close of business on June 26, 2026.
The board's action delivers a near-term cash distribution to shareholders and reiterates the company's routine capital-return practice. Contact information for investor relations and corporate communications is provided.
Humana (NYSE:HUM) and University of Chicago Medicine report a phone-based, pharmacist-led inhaler education program that improved technique among Medicare Advantage beneficiaries with COPD.
Of ~1,900 participants, inhaler misuse fell from nearly 40% at baseline to under 7% after the first phone session; multi-session follow-up helped sustain correct use across device types and subgroups.
Tuesday Health and Humana (NYSE: HUM) announced a partnership launching June 1, 2026 to expand value-based palliative care for eligible Humana members in Texas. The program offers interdisciplinary teams, in-person and virtual visits, 24/7 clinical access, symptom management and caregiver support.
According to the companies, the service is designed to improve quality of life, align care with patient goals, and extend Tuesday Health's national footprint.
Humana (NYSE: HUM) elected Robert S. Field to its Board of Directors effective immediately following the Company’s 2026 Annual Meeting of Stockholders on April 10, 2026. Field is Principal and Managing Member of ηMed Capital Management and has two decades of healthcare investing experience.
Humana said Field’s expertise in investment evaluation, risk oversight, capital allocation, and legal/regulatory dynamics will support the company’s strategy and Board refreshment, following shareholder engagement that included input from Sessa Capital.
Humana (NYSE:HUM) has gone live with b.well Connected Health to centralize member health data and support interoperability commitments on April 9, 2026. Humana will leverage b.well’s national network to access normalized longitudinal records across providers, plans, labs, wearables and digital apps in real time.
This collaboration supports Humana’s CMS Health Technology Ecosystem pledge, aims to reduce administrative waste, enable point-of-claims data access, and participates in an HHS interoperability demonstration.
Humana (NYSE:HUM) and CPESN® USA launched a Pharmacist Quality Rewards program in Ohio on April 8, 2026 to improve care for members with hypertension and diabetes. The value-based program financially rewards community pharmacists for closing care gaps tied to NCQA HEDIS measures including CBP, GSD (A1c <8%), and BPD.
Participating CPESN pharmacies receive member lists and point-of-care tools to identify gaps, offer same-day testing, notify prescribers of out-of-range results, and encourage follow-up care.
Humana (NYSE: HUM) released its corrected 2025 Impact Report on April 6, 2026, detailing progress on simpler, more affordable, and connected care.
Key metrics: nearly 8 million Medicare Advantage/PDP members supported, 1.48 million Medicaid members served, 24.3% fewer inpatient admissions in value‑based care, and a 38% vehicle fleet footprint reduction.